Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Yu

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Ecotoxicology and Environmental Safety|August 29, 2006
The H295R system for evaluation of endocrine-disrupting effectsTannia Gracia, Klara Hilscherova, Paul D Jones, et al.
Journal of Biomedical Nanotechnology|July 7, 2012
MR traceable delivery of p53 tumor suppressor gene by PEI-functionalized superparamagnetic iron oxide nanoparticlesH J Lee, Y T C Nguyen, M Muthiah, et al.
Toxicology and Applied Pharmacology|September 8, 2007
Modulation of steroidogenic gene expression and hormone production of H295R cells by pharmaceuticals and other environmentally active compoundsTannia Gracia, Klara Hilscherova, Paul D Jones, et al.
Biology of Reproduction|December 21, 2002
Expression, immunolocalization, and functional activity of Na+/H+ exchanger isoforms in mouse endometrial epitheliumX F Wang, M K Yu, S Y Lam, et al.
Chemosphere|March 4, 2008
Effects of fifteen PBDE metabolites, DE71, DE79 and TBBPA on steroidogenesis in the H295R cell lineRenfang Song, Yuhe He, Margaret B Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamideD E Rathkopf, M R Smith, C J Ryan, et al.
Oncogene|July 17, 2012
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancerC Xie, X H Jiang, J T Zhang, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Ecotoxicology and Environmental Safety|August 29, 2006
The H295R system for evaluation of endocrine-disrupting effectsTannia Gracia, Klara Hilscherova, Paul D Jones, et al.
Journal of Biomedical Nanotechnology|July 7, 2012
MR traceable delivery of p53 tumor suppressor gene by PEI-functionalized superparamagnetic iron oxide nanoparticlesH J Lee, Y T C Nguyen, M Muthiah, et al.
Toxicology and Applied Pharmacology|September 8, 2007
Modulation of steroidogenic gene expression and hormone production of H295R cells by pharmaceuticals and other environmentally active compoundsTannia Gracia, Klara Hilscherova, Paul D Jones, et al.
Biology of Reproduction|December 21, 2002
Expression, immunolocalization, and functional activity of Na+/H+ exchanger isoforms in mouse endometrial epitheliumX F Wang, M K Yu, S Y Lam, et al.
Chemosphere|March 4, 2008
Effects of fifteen PBDE metabolites, DE71, DE79 and TBBPA on steroidogenesis in the H295R cell lineRenfang Song, Yuhe He, Margaret B Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamideD E Rathkopf, M R Smith, C J Ryan, et al.
Oncogene|July 17, 2012
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancerC Xie, X H Jiang, J T Zhang, et al.
Pageof 5